PALLOTTA, MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 2.818
EU - Europa 2.338
AS - Asia 2.269
SA - Sud America 313
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 7.798
Nazione #
US - Stati Uniti d'America 2.741
SG - Singapore 986
IT - Italia 721
CN - Cina 356
HK - Hong Kong 305
VN - Vietnam 289
IE - Irlanda 282
BR - Brasile 225
FR - Francia 225
RU - Federazione Russa 214
DE - Germania 204
RO - Romania 179
FI - Finlandia 93
UA - Ucraina 90
GB - Regno Unito 81
IN - India 65
SE - Svezia 64
KR - Corea 45
BE - Belgio 40
CA - Canada 38
AR - Argentina 37
BD - Bangladesh 35
CZ - Repubblica Ceca 34
MX - Messico 25
NL - Olanda 25
TR - Turchia 25
JP - Giappone 24
IQ - Iraq 19
ID - Indonesia 17
PK - Pakistan 16
PL - Polonia 16
CO - Colombia 15
ZA - Sudafrica 15
AT - Austria 14
CH - Svizzera 14
ES - Italia 14
VE - Venezuela 14
EC - Ecuador 11
PH - Filippine 10
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
GR - Grecia 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
IL - Israele 5
JO - Giordania 5
LB - Libano 5
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
MA - Marocco 4
TH - Thailandia 4
CL - Cile 3
GT - Guatemala 3
KE - Kenya 3
KZ - Kazakistan 3
MK - Macedonia 3
OM - Oman 3
PE - Perù 3
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
KW - Kuwait 2
MT - Malta 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
NI - Nicaragua 1
PA - Panama 1
PF - Polinesia Francese 1
PR - Porto Rico 1
Totale 7.788
Città #
Singapore 750
Perugia 406
Chandler 329
Hong Kong 303
Dublin 282
San Jose 244
Ashburn 197
Dong Ket 167
Bucharest 155
San Mateo 140
Boardman 123
Beijing 110
Santa Clara 109
Munich 93
Moscow 81
Redmond 77
Los Angeles 72
Wilmington 66
Medford 58
Princeton 57
Lauterbourg 56
Altamura 55
Ann Arbor 54
Seoul 44
Lawrence 42
Brussels 40
Andover 39
Jacksonville 35
Ho Chi Minh City 34
New York 34
The Dalles 32
Council Bluffs 31
Dallas 27
Des Moines 27
Pisa 26
Helsinki 25
Turku 23
Chennai 21
Chicago 21
Hanoi 21
Rome 21
Falls Church 20
Tokyo 20
Dearborn 18
Olomouc 18
Orem 17
Redwood City 17
Denver 16
Saint Petersburg 16
Brno 15
Columbus 14
Montreal 14
Phoenix 14
São Paulo 14
West Jordan 14
Frankfurt am Main 13
Fremont 13
Johannesburg 13
Nuremberg 13
Piscataway 13
Norwalk 12
San Paolo di Civitate 12
Warsaw 12
Atlanta 11
Chiajna 11
Enfield 11
Guangzhou 11
Izmir 11
Poplar 11
Stockholm 11
Haiphong 10
Lappeenranta 10
Manchester 10
Milan 10
Măgurele 10
Terni 10
Amsterdam 9
Boston 9
Brooklyn 9
Hefei 9
Houston 9
London 9
Toronto 9
Woodbridge 9
Bologna 8
Da Nang 8
Mumbai 8
Nanjing 8
Querétaro 8
San Francisco 8
Abidjan 7
Buenos Aires 7
Rio de Janeiro 7
Riyadh 7
Vicenza 7
Baku 6
Caracas 6
City of London 6
Ottawa 6
San Diego 6
Totale 5.177
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 227
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 211
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 204
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 200
Amino-acid sensing and degrading pathways in immune regulation 196
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 183
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 182
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 179
Amino acid metabolism as drug target in autoimmune diseases 179
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 175
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 158
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 155
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 151
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 144
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 143
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 141
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 136
The TGF-β/IDO axis in infectious tolerance. 135
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 134
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 131
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 131
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 129
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 127
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 124
AhR-Mediated, Non-Genomic Modulation of IDO1 Function 121
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 119
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 118
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 117
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 115
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 110
Unconventional Pathways of Protein Secretion: Mammals vs. Plants 108
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 108
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 107
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 106
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 103
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 103
Extracellular Vesicles in Aging: An Emerging Hallmark? 101
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 100
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 100
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 100
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 98
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 97
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 96
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 94
Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production 93
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 92
IDO1 and TGF-β mediate protective effects of IFN-α in antigen-induced arthritis 90
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 88
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 85
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 85
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 84
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 83
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 82
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 82
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 80
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases foxp3+ T cells, and prolongs allogeneic corneal graft survival 79
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 76
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance 76
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 75
Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology 75
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 68
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Moonlighting Proteins Are Important Players in Cancer Immunology 62
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 61
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 60
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 57
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder 49
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 49
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 47
Gallic acid released by a layered double hydroxide-coated scaffold of hydroxyapatite and β-tricalcium phosphate inhibits the osteoclast formation In Vitro 21
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells 20
Totale 8.071
Categoria #
all - tutte 32.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 0 0 0 0 0 0 0 0 172
2021/2022861 8 106 15 18 28 17 6 153 101 116 94 199
2022/20231.122 61 190 16 84 105 99 2 64 388 14 87 12
2023/2024607 27 69 21 13 8 11 158 18 42 35 65 140
2024/20251.301 21 98 57 107 124 87 104 141 212 71 171 108
2025/20262.898 166 181 168 364 389 305 474 189 297 235 82 48
Totale 8.071